Fotolia/iStock via Getty Images JPMorgan recently raised its projections for weight loss drugs, expecting the drug category known as GLP-1 agonists to bring over $100B
Read MoreTag: JPMorgan
J.P Morgan To Launch AI Program To Boost AI Fintech Innovation In Partnership With TIFIN – JPMorgan Chase (NYSE:JPM)
In a significant move for the fintech sector, TIFIN, a leading artificial intelligence (AI) platform for wealth, and J.P. Morgan JPM have announced the launch of
Read More